
Learn the Medial Femoral Condyle Focal Resurfacing with HemiCAP(Arthrosurface) surgical technique with step by step instructions on OrthOracle. Our e-learning platform contains high resolution images and a certified CME of the Medial Femoral Condyle Focal Resurfacing with HemiCAP(Arthrosurface) surgical procedure.
Focal Resurfacing is gaining popularity for the treatment of focal articular defects up to 20x20mm in the knee (when using HemiCAP), providing a rapid recovery and no post-operative restrictions, differentiating this from biological reconstructive techniques such as cartilage grafting or the use of scaffolds such as Chondrogide . Biological reconstruction techniques usually require a period of reduced weightbearing up to 2 months and often a restricted range of movement range using a brace. Similarly the lack of post-operative restriction to activity differentiates focal resurfacing from traditional arthroplasty or even partial knee arthroplasty for the usually middle-aged patient with focal chondral damage.
The classic patient for focal resurfacing is in the 40-60 age range with a focal chondral lesion which is symptomatic and has failed traditional non-operative treatments such as offloader bracing and injection therapies such as visco-supplementation or steroid. Please remember to check alignment as osteotomy is an excellent proven treatment for the mal-aligned overloaded joint; focal resurfacing can be considered with or after osteotomy.
The HemiCAP was released in 2003, but it has taken some time to ‘catch on’ probably due to its innovative approach using a metal articular ‘cap’ inset within the articular surface. This is fundamentally different from partial knee replacement where there is a partial replacement on both sides of a joint.
There are now a number of implants available such as the HemiCAP, however it has the longest clinical experience and evidence base. Alternatives are the Bio-Poly, a cemented focal resurfacing which uses a novel combination of hyaluronic acid and polyethylene or the Epi-Sealer, a custom-made focal resurfacing relying on uncemented fixation with an option to cover defects up to 25mm in diameter.
All the focal resurfacings are designed to encourage the native chondral surrounding tissue to overgrow the margins of the inset implant.
The ArthroSurface HemiCAP condylar implant provides a surgical treatment for the painful chondral or osteochondral defect in the femoral condyles and has been in production since 2003. However the literature is sparse and as yet there is no independent guidance on its indications from the UK National Institute for Clinical Excellence (NICE) although this is planned a the time of writing (May 2021).
Since the initial design and release in 2003, there have been many evolutions of the design to allow for treatment of the patello-femoral joint (the ‘Wave’ or ‘Kahuna’ implant), the shoulder and the great toe.
The HemiCAP is an uncemented design and relies on cancellous fixation of the screw in the femoral condyle (the ‘fixation device’) and then the impaction of an Articular Component which matches the native anatomy via two sizes (15 and 20mm diameter) over 16 different curvatures. The two components combine with a morse taper.The Articular Component is made of Cobalt Chromium Alloy (Co-Cr-Mo) whilst the undersurface is Titanium plasma spray-coated and the morse taper is Titanium alloy (Ti-6Al-4V).
The largest metanalysis gives a revision rate of 9% at 4 years, but this includes all focal resurfacings and there have been longer terms studies at 7 years mean showing better outcome with condylar focal resurfacing. There is no doubt that at present the literature is still sparse, but all of the papers have been positive suggesting functional improvement in the vast majority of cases with a small reoperation and even lower revision rate.
At present focal resurfacings are not included in the National Joint Registry in the UK, but this is currently being debated and the relevant national bodies have been asked to comment on their future inclusion in the NJR. Please see the results section for the list of papers and summary results.

INDICATIONS
Unstable, painful chondral or osteochondral defects up to 20mm in diameter in the femoral condyles – medial or lateral. There is a patella-femoral variant of this implant made by ArthroSurface called the Wave for PFJ defects.
The defect should be unifocal – in other words it should only be on one side of the joint. Focal resurfacing is therefore not for ‘arthritis’ where there is joint failure on both sides of the joint. It is possible that patients have have progressed to arthritis from an initial chondral lesion and I therefore consent for proceeding to partial knee replacement of the affected side of the joint (Medial or Lateral) should there be bipolar defects on both femur and tibial sides.
In the young patient I would always try a biological reconstruction first – chondral grafting or scaffold (eg Chondrogide implantation). Historically microfracture or drilling has been performed although this is questioned now due to the risk of intra-lesional osteophytes and a poorer outcome with subsequent chondral regenerative techniques following microfracture.
Consequently there has been a resurgence of drilling and abrasion techniques (using a burr) and a less invasive microfracture technique called nano-fracture which requires a very simple aiming device with a central cannula for a small bore wire which penetrates the subchondral bone; hopefully this will have less side effects than microfracture.
The problem though with any regenerative technique is the lengthy rehab process and for that reason I am using more focal resurfacings in the middle-aged population to allow a clearer and simpler recovery pathway.
Focal resurfacings can always be used as the salvage for biological reconstruction and similarly partial knee replacement is the salvage for a potential failed focal resurfacing.
SYMPTOMS & EXAMINATION
Symptoms:
Localised pain over the affected compartment, most commonly the anteromedial knee – often the patient is able to locate the site of pain with one finger on the medial side of the knee. However if the patient is experiencing lateral femoral condylar damage then this pain and tenderness will be on the lateral side. Remember that for patellofemoral cases the pain is located anteriorly.
In this case however the classic symptoms of anteromedial pain and finger-pointing were found
Stiffness
Examination:
Tendereness in the anteromedial knee around the tibiofemoral joint line. Remember that for lateral or PFJ disease this will be in the relevant compartment and not the anteromedial knee; the rest of this examination is relevant to the anteromedial focal chondral lesion present in this case ( and the majority of focal chondral lesions)
Pain on loading in varus at 20-30 degrees of flexion.
No pain in the lateral joint on valgus loading – sometimes there may be exacerbation of the medial pain on valgus loading.
Intact ACL – or reconstructed ACL. The ACL should be functional – without this the knee will not work normally and degenerative progress is likely. However as we are seeing in the partial knee replacement space, extended indication proponents would debate this. For example if a patient was not functionally unstable even in the presence of ACL damage, use of a fixed bearing medial partial knee replacement (PKR) may still be appropriate. However the classical indication is an intact ACL
IMAGING
Radiographs– 4 views for all patients.
AP weight bearing– ideally long leg alignment views
Weight-bearing lateral
Skyline patella view
Rosenburg (PA flexion at 45)– this really stresses the lateral tibio-femoral compartment. If there is any suggestion of lateral wear then a stress XR should be performed with values to check the state of the Lateral TF joint under increased load.
Stress radiographs – only in selected cases – if the joint is failing then focal resurfacing is not the correct option and a partial knee replacement would be far more sensible. Please see :
Unicompartmental Knee replacement: Persona Partial Knee Replacement (Zimmer-Biomet)
In order to ensure that there is no full thickness disease on plain AP a varus stress view may be performed if there is clinical concern, but this is not my usual practice and in this case I just used radiograph and MRI.
MRI
All patients will have an MRI. Whilst MRI is the most objective modality of imaging the chondral surfaces (& excluding degenerative change of note), the sensitivity of this for chondral defects depends on the strength of the magnet and sequencing protocol; 1.5T is the current standard, but this is by no means perfect and all my cases are warned of the small chance of intra-operative conversion to a partial knee replacement if I find bifocal defects – damage on both sides of the medial tibio-femoral joint. MRI does allow assessment of intra-osseous bone marrow lesions which are markers of increased bone turnover.
ALTERNATIVE OPERATIVE TREATMENT
Arthroscopic Chondroplasty to remove unstable margins from the cartilage lesion. In full thickness disease, drilling and nano- or micro-fracture are still performed although there is debate regarding microfracture in particular. The vast majority of patients for focal resurfacing would have already undergone chondroplasty at least.
Chondral regenerative procedures – scaffolds or autologous chondrocyte implantation may well have been performed and failed. Whilst these treatments can certainly work, when they do not, focal resurfacing is a logical next step.
Osteotomy – if the long-leg alignment deviation is due to an extra-articular deformity then a realignment procedure can be performed in any age, although classically this is preferred for younger patients with optimal bone stock. Osteotomy surgery should be encouraged if alignment is abnormal.
Joint Arthroplasty – Partial or Total Knee Replacement – although in this case the defect is not full thickness loss and thus arthroplasty (partial or total) is not indicated.
NON-OPERATIVE MANAGEMENT
Lifestyle modifications
Analgesia
Bracing – medial offloader braces which push the knee into valgus.
Injection therapy – steroid for inflammation, or viscosupplementation for stiffness and pain. Platelet Rich Plasma Injections such as N-Stride from Zimmer Biomet.
CONTRAINDICATIONS
Absolute
Active infection
Active inflammatory arthritis in the same joint
Untreated and symptomatic ligament laxity
Relative
Inflammatory arthritis in other joints
ACL damage
Significant loss of range of movement – focal resurfacing will not improve range.

My setup for this operation is usually as shown in:
Unicompartmental Knee replacement: Persona Partial Knee Replacement (Zimmer-Biomet)
However in this case I was also performing a tibial tubercle osteotomy and therefore I chose my ‘TKR setup’ as in
Total knee replacement: Vanguard XP cruciate retaining (Zimmer-Biomet)
Two main operative setups are used for focal resurfacing;
Leg holder – the operative thigh is held on or in a leg holder such that the knee can flex freely and hang dependently under gravity. The surgeon may sit or stand. If a sitting style is chosen consider a surgical stool whose height may be altered with a foot pedal intra-operatively by the surgeon
As a standard TKR position with side support and foot roll. Surgeon standing
Tourniquet
Where a surgeon chooses to use a tourniquet this should be applied at the start of the operation high on the thigh before skin preparation.
My personal choice is to avoid the tourniquet and so attention must be paid to haemostasis during the procedure. Simple techniques such as raising the feet of the operating table and instillation of local anaesthetic with adrenaline at the start of procedure are sensible.
Drugs
Intravenous prophylactic antibiotics should be administered early (30-45 minutes) to achieve adequate tissue concentrations at the time of ‘knife to skin’. We use Cetriaxone as a one-off dose.
Intravenous tranexamic acid on induction – 1000mg.
If the wound is oozing then this induction dose can be repeated on closure.
The leg, and knee in particular, is freely accessible by using a thigh holder.
The thigh holder I favour is that designed by David Murray of the Nuffield Orthopaedic centre, Oxford, which allows deep knee flexion. It is available through Zimmer Biomet Product number 32-420950.
My standard layout of the sterile field. The surgeon is seated with patient’s leg surrounded by sterile drapes and the assistant is standing proximally towards the patient’s head. The Scrub Nurse stands on the opposite side with easy access to the Mayo table for instruments.

Standard care postoperatively
Antibiotics: single dose of Ceftriaxone given on induction – no further doses required.
Hospital Stay: increasingly this is day case surgery.
Weight Bearing: full weight bear as soon as possible.
Bloods: Full blood count, Urea, Electrolytes and Creatinine
Radiograph: Anteroposterior and lateral XR
Dressing: left in situ for 2 weeks, ideally undisturbed from theatre, but changed on the rare occasions that the wound leaks.
Venous thromboembolism prophylaxis: Aspirin 150mg for 6 weeks orally for standard risk. Patients with previous VTE receive 10 days of low molecular weight heparin (LMWH) in addition to their Aspirin. Patients on prophylactic long term anticoagulants including NOACs should simply return to their normal medication on day 2, using LMWH at prophylactic dose on day 1.
Follow-up – depending on the patient’s functional ability we usually ask them to remove their own dressing at 2 weeks, but where this is impractical we review in our outpatient department at 2 weeks. Subsequent review is scheduled as: 6-8 weeks, 12 months, 2 years, 7, 10,13 years continuing every 3 years as per UK National Guidance
Variance – Any concerns with the wound should trigger a review by the treating surgical team and must not be managed in the community.

Bollars P, Bosquet M, Vandekerckhove B, Hardeman F, Bellemans J. Prosthetic inlay resurfacing for the treatment of focal, full thickness cartilage defects of the femoral condyle: a bridge between biologics and conventional arthroplasty. Knee Surg Sports Traumatol Arthrosc. 2012 Sep;20(9):1753-9. doi: 10.1007/s00167-011-1757-9. Epub 2011 Nov 11. PMID: 22076054.
In one of the first papers of a series of HemiCAPs, Bollars reported on a series of 27 patients, reduced to 19 after exclusions, who were reviewed at a mean of 34 months. 83% showed normal or near-normal IKDC scores and the mean WOMAC was 90 showing very good functional results.
Becher C, Kalbe C, Thermann H, Paessler HH, Laprell H, Kaiser T, Fechner A, Bartsch S, Windhagen H, Ostermeier S. Minimum 5-year results of focal articular prosthetic resurfacing for the treatment of full-thickness articular cartilage defects in the knee. Arch Orthop Trauma Surg. 2011 Aug;131(8):1135-43. doi: 10.1007/s00402-011-1323-4. Epub 2011 Jun 4. PMID: 21643800.
Christoph Becher looked at a series of patients with focal resurfacings at a minimum of 5 years and found 16/21 were satisfied.
This was then followed with a case series of two case from the same author with 12 year follow-up, showing good clinical outcome, retained implants as well as a review of the literature of 6 papers:
Becher C, Cantiller EB. Focal articular prosthetic resurfacing for the treatment of full-thickness articular cartilage defects in the knee: 12-year follow-up of two cases and review of the literature. Arch Orthop Trauma Surg. 2017 Sep;137(9):1307-1317. doi: 10.1007/s00402-017-2717-8. Epub 2017 May 19. PMID: 28526923.
Fuchs A, Eberbach H, Izadpanah K, Bode G, Südkamp NP, Feucht MJ. Focal metallic inlay resurfacing prosthesis for the treatment of localized cartilage defects of the femoral condyles: a systematic review of clinical studies. Knee Surg Sports Traumatol Arthrosc. 2018 Sep;26(9):2722-2732. doi: 10.1007/s00167-017-4714-4. Epub 2017 Sep 16. PMID: 28918523.
The metanalysis by Fuchs of 187 patients with focal resurfacing at medium term found a 9% revision rate for HemiCAP at mean of 4 years.
Laursen JO, Backer Mogensen C, Skjøt-Arkil H. HemiCAP Knee Implants: Mid- to Long-Term Results. Cartilage. 2019 Dec 21:1947603519894732. doi: 10.1177/1947603519894732. PMID: 31867991.
Laursen et al found significant clinical improvement in patient reported outcome at a mean of 7 years (4-10 years range) in 64 Hemicaps (62 patients) with focal resurfacings; of these 64 implants 36 were HemiCAP condylar implants.
Nahas S, Monem M, Li L, Patel A, Parmar H. Ten-Year Average Full Follow-up and Evaluation of a Contoured Focal Resurface Prosthesis (HemiCAP) in Patients in the United Kingdom. J Knee Surg. 2020 Oct;33(10):966-970. doi: 10.1055/s-0039-1688921. Epub 2019 May 24. PMID: 31127601.
Nahas et al showed excellent patient reported outcomes at 10 years in a consecutive single surgeon series of 10 HemiCAPs.
van Buul GM, Stanclik J, van der Stok J, Queally JM, O’Donnell T. Focal articular surface replacement of knee lesions after failed cartilage repair using focal metallic implants: A series of 132 cases with 4-year follow-up. Knee. 2021 Mar;29:134-141. doi: 10.1016/j.knee.2021.01.014. Epub 2021 Feb 19. PMID: 33610953.
In a prospectively collected series of 107 Condylar HemiCAP implants within a series of 137 focal resurfacings, there was a 12% re-operation rate at 4 years and a 97% survival of implant rate. Significant PROM improvements were reported.
Reference
- orthoracle.com

































































